Author

Rebecca Jordache

Observed names: R Jordache, R. Jordache

Observed institutions: St George's Hospital, Royal Surrey County Hospital, Cwm Taf University Health Board, Royal Surrey NHS Foundation Trust, Prince Charles Hospital, Cardiff University

ORCID: 0009-0001-5751-0146

Observed ORCID: 0009-0001-5751-0146

OpenAlex ID: A5048461445

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 566

PDF

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 512

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 402

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 361

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 303

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 141

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 45

PDF

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 42

PDF

Four consecutive yearly point-prevalence studies in Wales indicate lack of improvement in sepsis care on the wards

2021 · Maja Kopczynska, Harry Unwin, et al. · Scientific Reports · 17

PDF

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 15

PDF

Preliminary Adaptation, Development, and Testing of a Team Sports Model to Improve Briefing and Debriefing in Neonatal Resuscitation

2020 · Rebecca Jordache, Cora Doherty, et al. · Pediatric Quality and Safety · 13

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2024 · RECOVERY Collaborative Group, Peter Sandercock, et al. · Nature Communications · 12

PDF

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 8

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 5

PDF

P029: Can two week wait breast cancer referrals be triaged to prioritise high risk patients for early diagnosis and treatment?

2020 · Sarah Blacker, Rebecca Jordache, et al. · European Journal of Surgical Oncology · 5

Journal update monthly top five

2026 · Lydia Zioupos, Micha Fernandez, et al. · Emergency Medicine Journal

651 Can Two Week Wait Breast Cancer Referrals Be Triaged to Prioritise High Risk Patients for Early Diagnosis and Treatment?

2021 · S Blacker, R Jordache, et al. · British journal of surgery

PDF

Works count: 20

Citation count: 2,515

H-index: 13

I10-index: 14